Mucormycosis in the diabetic patient

Mucormycosis is a rare, devastating, fungal infection, which disproportionately affects non-controlled diabetic patients, notably during ketoacidosis. It can be manifested in rhinocerebral, but also pulmonary and disseminated forms. Four consecutive diabetic patients who were admitted to the Farhat...

Full description

Saved in:
Bibliographic Details
Published in:La Presse médicale (1983) 2005-02, Vol.34 (3), p.218-222
Main Authors: Chadli-Chaieb, M, Bchir, A, Fathallah-Mili, A, Ach, K, Maaroufi, A, Garrouche, A, Chaieb, L
Format: Article
Language:fre
Subjects:
Adolescent
Adult
Aged
Amphotericin B - therapeutic use
Antifungal Agents - therapeutic use
Debridement
Diabetes Mellitus, Type 1 - complications
Diabetes Mellitus, Type 2 - complications
Fatal Outcome
Female
Humans
Mucormycosis - etiology
Mucormycosis - pathology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mucormycosis is a rare, devastating, fungal infection, which disproportionately affects non-controlled diabetic patients, notably during ketoacidosis. It can be manifested in rhinocerebral, but also pulmonary and disseminated forms. Four consecutive diabetic patients who were admitted to the Farhat Hached Hospital, Sousse, Tunisia, between January 2001 and November 2002, are presented. Three patients exhibited ketoacidosis and one renal failure with hyperosmolarity. Infection was limited to the sinuses in two cases, to lower respiratory tract in one case, and was probably disseminated in one case. Diagnosis was confirmed by mycological and histological findings in all cases. Systemic Amphotericin B was associated with surgical debridement of the lesions in patients with rhinocerebral involvement. Despite aggressive therapy, mortality was high (3 out of 4 patients). Mucormycosis remains a severe, frequently fatal disease in diabetic patients.
ISSN:0755-4982
2213-0276
DOI:10.1016/S0755-4982(05)88251-X